NDASUBCUTANEOUSINJECTABLE
Approved
Aug 2016
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
13
Mechanism of Action
Serotonin 3 Receptor Antagonists
Pharmacologic Class:
Serotonin-3 Receptor Antagonist
Clinical Trials (5)
Safety Study of Repeat Doses of SUSTOL in Adults
Started Jul 2022
Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.
Started Jul 2021
134 enrolled
Healthy Volunteers
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting
Started Aug 2020
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
Started Jan 2019
0Gastroparesis
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Started Mar 2014